Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Altmueller, Janine Dr.med. (29) Bunse, Mario Dr. (1) Fischer, Cornelius Dr. (1) Graf, Robin Dr. (2) Harabula, Izabela-Cezara (1) Hirsekorn, Antje (2) Kammertöns, Thomas Dr. (5) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (1) Kühn, Ralf Dr. (14) Lacadie, Scott Allen Dr. (2) Landthaler, Markus Prof. Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lupianez Garcia, Dario Jesus Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (15) Pezzutto, Antonio Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (2) Selbach, Matthias Prof. Dr. (2) Uckert, Wolfgang Prof. Dr. (2) Vucicevic, Dubravka (1) Willimsky, Gerald Dr. (5) Zauber, Henrik Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (15) (-) Chu, Van Trung Dr. (2) (-) Wyler, Emanuel Dr. (1) (-) Bioinformatik der Genregulation (1) Experimentelle Ultrahochfeld-MR (5) Genetik metabolischer und reproduktiver Störungen (1) (-) Genom-Editierung & Krankheitsmodelle (2) Immunregulation und Krebs (3) Magnetic Resonance (5) (-) Molekulare Immunologie und Gentherapie (15) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Transgenics (2) Zelluläre Neurowissenschaften (2) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) (-) 2013 (11) 2014 (3) 2015 (6) (-) 2016 (7) 2017 (7) 2018 (4) 2019 (11) 2020 (1) 2021 (5) 2022 (9) 2023 (6) 2024 (3) 18 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Chu, Van Trung Dr.Wyler, Emanuel Dr.Bioinformatik der GenregulationGenom-Editierung & KrankheitsmodelleMolekulare Immunologie und Gentherapie 20132016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky 05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein 01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein 01. Mai 2013 / Canc Res Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens J Zhang L Chen X Liu T. Kammertoens T. Blankenstein Z. Qin 15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein 15. April 2013 / Canc Cell It's the peptide-MHC affinity, stupid T. Kammertoens T. Blankenstein 01. August 2013 / Canc Res Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T cell transplantation R. Hess Michelini T. Manzo T. Sturmheit V. Basso M. Rocchi M. Freschi J.J. Listopad T. Blankenstein M. Bellone A. Mondino 01. August 2013 / Nat Protoc Generation of transgenic mice with megabase-sized human yeast artificial chromosomes by yeast spheroplast-embryonic stem cell fusion L. Li T. Blankenstein 01. Dezember 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
01. Mai 2013 / Canc Res Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens J Zhang L Chen X Liu T. Kammertoens T. Blankenstein Z. Qin
15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein
01. August 2013 / Canc Res Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T cell transplantation R. Hess Michelini T. Manzo T. Sturmheit V. Basso M. Rocchi M. Freschi J.J. Listopad T. Blankenstein M. Bellone A. Mondino
01. August 2013 / Nat Protoc Generation of transgenic mice with megabase-sized human yeast artificial chromosomes by yeast spheroplast-embryonic stem cell fusion L. Li T. Blankenstein
01. Dezember 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya